Companies / BOC Sciences / Pivekimab
BOC Sciences

Pivekimab | BOC Sciences

Pivekimab is a human anti-IL-3 monoclonal antibody. Pivekimab can be used in the synthesis of ADC Pivekimab sunirine, which is developed for the treatment of hematological malignancies.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.